Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001406908 | SCV001608871 | likely benign | Gorlin syndrome; Medulloblastoma | 2022-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420667 | SCV002677585 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003488740 | SCV004241784 | likely benign | not specified | 2023-12-31 | criteria provided, single submitter | clinical testing |